Nucala 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FDQXV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,357
Award facts
- Contract value 100% obligated
- $11,357.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,357.40 to DMS Pharmaceutical Group Inc. for NUCALA 100 mg/mL syringes on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 through the SPE2DB program. NUCALA is a biologic medication used to treat moderate-to-severe eosinophilic asthma and other eosinophil-mediated conditions, indicating this delivery supports pharmaceutical supply requirements for Department of Defense healthcare facilities.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has established itself as a key supplier in the federal pharmaceutical distribution network. The company specializes in delivering a comprehensive portfolio of branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. This particular delivery order reflects the company's continued role in fulfilling medication supply needs for the Defense Logistics Agency, which manages pharmaceutical inventory and distribution to support military medical operations globally.
Quick answers
Who was awarded contract SPE2DB25FDQXV?
SPE2DB25FDQXV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FDQXV worth?
The government has obligated $11,357 on SPE2DB25FDQXV.
Is contract SPE2DB25FDQXV an order under another contract?
Yes. SPE2DB25FDQXV is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQXV competed?
The extent of competition for SPE2DB25FDQXV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award